The Youth Paradox of Chronological Age Discordance and the Biological and Lifestyle Determinants Behind It

Introduction

The observation that some individuals appear significantly younger than their chronological age has long fascinated both scientists and the general public. Walk into any gathering of 50-year-olds, and the biological heterogeneity becomes immediately apparent, some possess the skin elasticity, muscle tone, and vitality of someone decades younger, while others display advanced markers of aging that make them appear older than their years. This phenomenon, often casually attributed to “good genes” or favourable genetics, in fact reflects a far more complex interplay of molecular, cellular, and lifestyle factors that collectively determine our rate of biological aging. While chronological age advances uniformly for everyone at one year per year, biological age, he true measure of physiological wear and tear on our systems can vary dramatically between individuals of the same age cohort, with divergences of 10-20 years or more commonly observed in aging research cohorts.

The past two decades have witnessed remarkable advances in longevity science and aging research, transforming our understanding of why some individuals age more slowly than others. The development of epigenetic clocks, telomere analysis, and multi-omic profiling technologies has enabled researchers to quantify biological aging with unprecedented precision, moving beyond subjective assessments to objective, measurable biomarkers. These tools have revealed that youthful appearance is not merely superficial vanity but often mirrors deeper biological preservation at the cellular and molecular levels. Individuals who look younger typically show slower accumulation of senescent cells, better-preserved telomeres, more favourable DNA methylation patterns, and superior metabolic function compared to their chronologically matched peers who appear older. This concordance between perceived age and biological age suggests that visible youthfulness serves as an external indicator of internal health, a phenotypic manifestation of slower aging across multiple physiological systems.

Understanding these “youth factors” has profound implications for preventive medicine and longevity interventions, shifting the paradigm from treating age-related diseases reactively to proactively modulating the aging process itself. If we can identify the determinants that distinguish biological age accelerators from decelerators, we can potentially develop targeted interventions to slow aging trajectories before pathology manifests. This represents a fundamental reconceptualization of healthcare, moving upstream to address the root biological processes of aging rather than managing downstream to address the root biological processes of aging rather than managing downstream consequences. The potential impact extends beyond individual health to public health and healthcare economics, as compressing morbidity and extending health span could dramatically reduce the burden of age-related chronic diseases that currently consume the majority of healthcare resources in aging populations.

This article examines the multifaceted determinants of biological age deceleration, synthesizing current evidence from molecular biology, epigenetics, metabolism, and lifestyle medicine. We explore how cellular senescence and epigenetic modifications create the biological foundation of aging; how metabolic flexibility and glucose regulation influence aging trajectories; how lifestyle factors including diet, exercise, sleep, and stress management modulate biological age; and how emerging interventions from hormetic stressors to senolytic compounds may offer novel approaches to age deceleration. By providing a comprehensive, evidence-based framework for understanding the mechanisms underlying youthful aging, we aim to equip clinicians and researchers with actionable knowledge to translate longevity science into practical interventions. Ultimately, the goal is not merely to understand why some people look younger, but to democratize access to the biological, metabolic, and lifestyle strategies that enable more individuals to preserve vitality, function, and yes, youthful appearance throughout extended, high-quality lifespans.

The Biology of Biological Age

Hallmarks of Aging and age Acceleration

The aging process is fundamentally characterized by a constellation of interconnected biological mechanisms that progressively compromise cellular and organismal function over time. In their seminal 2013 framework, López-Otín and colleagues identified nine hallmarks of aging, which was subsequently expanded to twelve hallmarks in their 2023 update to reflect emerging scientific understanding. These hallmarks, genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, deregulated nutrient-sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation, and dysbiosis fulfil three essential criteria: they manifest during normal aging, their experimental accentuation accelerates aging, and their therapeutic amelioration can decelerate, arrest, or potentially reverse aspects of the aging process [1,2].

Figure 1. The hallmark of aging, including the nine original ones and the three added in the second version, as well as their classification into primary antagonistic and integrative [2]

These hallmarks are not isolated phenomena but rather operate as an interconnected network where perturbations in one domain cascade into others, creating a self-reinforcing cycle of physiological decline. The hallmarks are conceptually organized into primary hallmarks (initial causes of cellular damage), antagonistic hallmarks (compensatory responses that initially protect but become harmful when chronic), and integrative hallmarks (systemic consequences affecting tissue homeostasis). Individuals who appear significantly younger than their chronological age typically exhibit slower accumulation of these age-related molecular and cellular changes across multiple domains simultaneously. This suggests that youthful aging represents not merely protection against one or two aging mechanisms, but rather a coordinated preservation of cellular and systemic integrity across the entire hallmark spectrum [2].

Biological age can now be quantified through various objective biomarkers that capture distinct facets of the aging process. These include DNA methylation patterns measured through epigenetic clocks, telomere length in circulating leukocytes, systemic inflammatory markers (such as IL-6, CRP, and TNF-α), advanced glycation end products (AGEs) accumulated in tissues and circulation, and more recently, glycan profiles and multi-omic signatures. Each biomarker provides complementary information: telomere length reflects cumulative cell division history and oxidative stress exposure; inflammatory markers capture immune system dysregulation; AGEs quantify metabolic damage from glucose-protein interactions; and epigenetic clocks integrate methylation changes across hundreds of genomic sites to produce a composite biological age estimate [1,3].

Compelling evidence demonstrates that perceived age, the age individuals appear to observers correlates strongly with these objective biological age biomarkers and predicts health outcomes. A landmark 2009 Danish twin study established that perceived age is a robust biomarker of aging that predicts survival even after controlling for chronological age, sex, and rearing environment. The study found that perceived age correlated significantly with physical and cognitive functioning as well as with leucocyte telomere length, suggesting that visible youthfulness genuinely reflects deeper cellular preservation rather than superficial cosmetic features. Twin analyses within this cohort revealed that common genetic factors influence both perceived age and survival, while the likelihood that the older-looking twin died first increased proportionally with the magnitude of perceived age discordance between twins. These findings validate the clinical intuition that “looking old for one’s age” represents a meaningful biological signal rather than subjective assessment bias [3].

The Epigenetic Clock and Methylation Patterns

Among the various biological age biomarkers, DNA methylation-based age estimators, commonly termed epigenetic clocks have emerged as perhaps the most transformative tools for quantifying biological aging with single-year precision. The development of the Horvath (2013) and Hannum (2013) epigenetic clocks represented a paradigm shift in aging research, enabling objective, reproducible measurement of biological age from tissue samples. The Horvath clock, also known as the pan-tissue clock, analyzes methylation patterns across 353 specific CpG sites and can predict biological age across diverse tissue and cell types with remarkable accuracy. The Hannum clock, derived from whole blood samples, examines 71 CpG sites and demonstrates particularly strong performance in blood-based aging assessment [4,5].

These epigenetic clocks function by identifying specific genomic regions where DNA methylation, the addition of methyl groups to cytosine bases changes predictably with age. The pattern of methylation across these sites creates a molecular signature that reflects biological rather than merely chronological aging. Individuals who look younger often exhibit “age deceleration”, their epigenetic age (DNAmAge) lags behind their chronological age by several years, indicating slower biological aging at the molecular level. Conversely, epigenetic age acceleration (DNAmAge exceeding chronological age) associates with increased mortality risk and age-related disease burden. Studies of exceptionally long-lived individuals, including centenarians, consistently demonstrate that they possess younger epigenetic ages compared to their chronological ages, with some showing negative age acceleration, biological ages substantially younger than their actual years lived [5].

Perhaps most encouraging for interventional gerontology, mounting evidence indicates that epigenetic age is not immutable but can be modified through targeted lifestyle interventions. A groundbreaking 2021 randomized controlled clinical trial conducted among 43 healthy adult males aged 50-72 demonstrated that an eight-week program combining dietary modifications, sleep optimization, exercise, and stress management reduced biological age by an average of 3.23 years compared to controls (p=0.018), as measured by the Horvath DNAmAge clock. The treatment group showed an average decrease of 1.96 years compared to baseline measurements, with a strong trend toward significance. This intervention included a nutrient-dense diet emphasizing methylation-supportive foods (leafy greens, cruciferous vegetables, beets), limited animal protein (primarily liver and eggs), carbohydrate restriction with mild intermittent fasting to reduce glycemic cycling, supplementation with polyphenol-rich fruit and vegetable powder and probiotics, at least 30 minutes of exercise daily at 60-80% maximum perceived exertion, sleep optimization to at least 7 hours nightly, and twice-daily breathing exercises for stress management [6,7].

A subsequent 2023 case series of six women following a similar methylation-supportive program demonstrated even more pronounced effects, with an average reversal of epigenetic biological age of 4.60 years (p=0.039) over the eight-week intervention period. These findings collectively suggest that the epigenetic aging process exhibits substantial plasticity and can be meaningfully decelerated or partially reversed through comprehensive lifestyle optimization, even over relatively short timeframes. The magnitude of biological age reduction achieved, equivalent to 3-5 years in just 8 weeks exceeds what would be expected from measurement variability alone and represents a clinically meaningful shift in aging trajectories. These interventions work by modulating DNA methyltransferase (DNMT) activity through dietary methyl donors (folate, betaine, choline), polyphenolic DNMT modulators, and lifestyle factors that influence the broader epigenetic landscape, ultimately recalibrating the methylation patterns that constitute biological age [6].

Genetic Architecture of Youthful Aging

Longevity Genes and Protective Variants

While lifestyle factors clearly play a dominant role in determining biological aging trajectories, genetics establish the boundaries within which environmental interventions operate. Traditionally, heritability estimates from twin studies have suggested that genetics contribute approximately 20-30% to human longevity and age-related phenotypes, with the remaining 70-80% attributable to environmental and lifestyle factors. However, a groundbreaking 2026 study published in Science challenges this consensus, demonstrating that when extrinsic mortality (deaths from accidents, infections, and other non-aging-related causes) is properly accounted for, the intrinsic heritability of human lifespan approaches approximately 50%, more than double previous estimates. This revision suggests that genes play a substantially larger role in determining longevity potential than previously recognized, with profound implications for understanding the genetic architecture of youthful aging and identifying actionable targets for intervention [8,9].

Among the numerous genetic variants associated with longevity, the FOXO3 gene stands out as perhaps the most robustly replicated longevity-associated gene across diverse populations and ethnic groups. FOXO3 encodes a transcription factor belonging to the Forkhead box O family that serves as a master regulator of cellular stress resistance, metabolism, autophagy, and DNA repair. Carriers of protective FOXO3 single nucleotide polymorphisms (SNPs) demonstrate significantly reduced cardiovascular disease risk and extended health span, with longevity-associated variants correlating with lower-than-average morbidity from cardiovascular diseases in long-lived individuals. Intriguingly, recent evidence reveals that FOXO3’s longevity effects are context-dependent: a 2020 study found that longevity-associated FOXO3 variants prolong lifespan specifically in individuals with cardiometabolic diseases (diabetes, hypertension, coronary heart disease), but show no effect in healthy individuals without these conditions. Men with cardiometabolic diseases who carried the protective FOXO3 genotype exhibited mortality rates equivalent to healthy men without such conditions (hazard ratio 0.81, 95% CI 0.72-0.91), suggesting that FOXO3 functions as a “resilience gene” that confers protection against aging-related stressors rather than extending lifespan universally [10,11,12,13].

The mechanistic basis for FOXO3’s protective effects involves multiple interconnected pathways. FOXO3 activation enhances cellular stress resistance by upregulating antioxidant enzymes (superoxide dismutase, catalase), promotes autophagy and mitophagy to clear damaged cellular components, improves DNA repair capacity, and modulates inflammatory responses. In vascular tissues specifically, FOXO3 plays critical roles in maintaining endothelial function, regulating smooth muscle cell proliferation, and protecting against oxidative stress-induced vascular aging. Experimental studies using FOXO3-engineered human embryonic stem cell-derived vascular cells demonstrate improved vascular homeostasis and delayed vascular aging, supporting the translational potential of targeting this pathway [10,11].

Beyond FOXO3, other notable longevity genes include those involved in the growth hormone (GH) and insulin-like growth factor 1 (IGF-1) signalling pathways. Paradoxically, while adequate GH and IGF-1 are necessary for normal development and tissue maintenance, mild attenuation of this signalling pathway associates with extended longevity across species from yeast to mammals. Studies of exceptionally long-lived individuals, including centenarians and their offspring, consistently reveal reduced IGF-1 signalling relative to average-lived controls. For example, functional mutations in the IGF-1 receptor (IGF1R) gene that reduce receptor abundance and downstream signalling are more prevalent in centenarians than age-matched controls, and associate with unique phenotypes including increased serum IGF-1 levels but decreased cellular IGF-1 sensitivity. Lymphocytes from centenarians carrying IGF1R mutations show decreased IGF-1 receptor abundance and reduced phosphorylation of the downstream signalling molecule Akt in response to IGF-1 stimulation, indicating attenuated pathway activity [14].

This IGF-1/GH paradox appears protective against age-related diseases through multiple mechanisms. Reduced IGF-1 signalling shifts cellular metabolism from proliferation toward maintenance and repair activities, decreases oxidative stress generation, enhances stress resistance pathways, reduces accumulation of senescent cells, and improves metabolic efficiency. The endocrine and metabolic adaptation observed in centenarians, characterized by reduced IGF-1 signalling, enhanced insulin sensitivity, and preferential nutrient allocation toward cellular repair may represent a physiological strategy for extending lifespan through slower cellular metabolism, better physiologic reserve capacity, and decreased damage accumulation. Importantly, this pathway is modifiable through lifestyle interventions: caloric restriction, intermittent fasting, and protein restriction all reduce IGF-1 levels and may partially replicate the longevity-associated metabolic phenotype observed in genetic centenarians. The implications for youthful appearance are significant, as reduced oxidative stress, enhanced cellular repair mechanisms, and slower cellular turnover collectively preserve tissue structure and function, including skin integrity and regenerative capacity [15].

Collagen Genetics and Dermal Aging

While systemic longevity genes influence whole-body aging trajectories, skin appearance, the most visible marker of biological age, is additionally shaped by genetic variants specifically affecting dermal structure and maintenance. Type I collagen constitutes approximately 80-90% of dermal collagen and provides the structural scaffolding that maintains skin firmness, elasticity, and tensile strength. The COL1A1 gene, which encodes the α1 chain of type I collagen, contains several polymorphisms that significantly influence dermal aging trajectories and visible skin aging phenotypes [16,17].

The rs1800012 polymorphism in COL1A1 represents one of the most extensively studied variants in relation to skin aging. This single nucleotide polymorphism has been associated with alterations in both collagen production rates and susceptibility to degradation, potentially weakening dermal structural integrity and contributing to visible signs of skin aging including wrinkle formation, reduced skin firmness, and loss of elasticity. Individuals carrying risk variants demonstrate accelerated collagen breakdown and impaired collagen synthesis efficiency, shifting the balance between collagen production and degradation toward net collagen loss. Beyond COL1A1, polymorphisms in the related COL1A2 gene (encoding the α2 chain of type I collagen) also influence collagen fiber assembly, cross-linking patterns, and structural stability, collectively determining individual susceptibility to both intrinsic and extrinsic skin aging [17,18].

Equally important to collagen synthesis genes are the matrix metalloproteinase (MMP) genes, which encode enzymes responsible for controlled degradation and remodelling of extracellular matrix components including collagen. The MMP family comprises over 28 different zinc-containing endopeptidases with varying substrate specificities, collectively capable of degrading all extracellular matrix proteins. Among these, MMP-1 (interstitial collagenase) specifically cleaves fibrillar type I and type III collagen, the predominant collagens in dermal tissue and represents a primary determinant of collagen turnover rates in skin. As skin ages, MMP-1 expression tends to increase while collagen production declines, creating an imbalance that accelerates collagen depletion, loss of dermal thickness, and wrinkle formation [19].

Figure 2. Schematic diagram showing the role of MMPs in photoaging [19].

Genetic variations in MMP genes significantly modulate individual susceptibility to photoaging, the extrinsic aging process driven primarily by ultraviolet radiation exposure. Polymorphisms in the MMP-1 promoter region (particularly the 1G/2G polymorphism) influence baseline MMP-1 expression levels and responsiveness to UV-induced upregulation. Individuals carrying high-expression MMP-1 variants demonstrate accelerated collagen breakdown following UV exposure, manifesting as increased wrinkle severity, loss of skin elasticity, and textural changes compared to those with low-expression variants. Similarly, genetic variants in MMP-2 and MMP-9 (gelatinases that degrade type IV collagen at the dermal-epidermal junction) influence basement membrane integrity and contribute to age-related flattening of the dermal-epidermal junction [17,19,20].

Metabolic Determinants of Biological Age

Glucose Metabolism and Glycation

Chronic hyperglycemia represents one of the most potent accelerators of biological aging, operating through multiple interconnected mechanisms that extend far beyond pancreatic β-cell dysfunction or insulin resistance. The most prominent aging mechanism involves the formation of advanced glycation end products (AGEs), irreversible post-translational modifications that accumulate in long-lived proteins throughout the lifespan. AGEs form through non-enzymatic reactions between reducing sugars (particularly glucose and ribose) and free amino groups on proteins, lipids, and nucleic acids, progressing from reversible Schiff bases through stable Amadori products (such as hemoglobin A1c) to ultimately generate complex, irreversible crosslinked AGE structures. Among the various AGE species, glucosepane, a lysine-arginine crosslink, represent the most abundant AGE in human tissues and the predominant crosslink in aged collagen [21,22,23].

The accumulation of AGEs in dermal and vascular tissues produces profound structural and functional consequences that manifest as visible aging. In skin specifically, AGE-mediated collagen and elastin crosslinking disrupts the normal fibrillar architecture, causing proteins to become “glued together” in aberrant configurations that increase tissue stiffness while reducing elasticity and resilience. This crosslinking manifests clinically as skin stiffness, wrinkle formation, loss of elasticity, and the characteristic yellowing of aged skin, changes observed dramatically in diabetic patients who experience accelerated AGE accumulation due to sustained hyperglycemia. Mechanistic studies demonstrate that ribose treatment of tendons induces striking coloration changes from pearl-white to golden-yellow within 28 days, accompanied by altered molecular spacing, reduced D-period length, and profoundly diminished viscoelasticity due to restricted fiber-to-fiber and fibril-to-fibril movement. Beyond structural modifications, AGEs exert additional pathological effects by binding to cellular receptors for AGEs (RAGE), triggering inflammatory cascades through NF-κB activation, promoting fibroblast apoptosis via ROS generation and FOXO1 activation, and reducing the expression of cathepsin D (CatD), an enzyme responsible for AGE degradation, thereby creating a positive feedback loop that accelerates AGE accumulation and photoaging [21,22,23,24,25].

Importantly, AGE accumulation is not limited to extremes of dysglycemia but occurs progressively throughout normal aging, with rates determined by both average glucose exposure and glucose variability. Individuals who maintain superior glucose regulation, characterized by minimal postprandial spikes, high time-in-range (typically defined as 70-140 mg/dL in metabolically healthy individuals), and low glycemic variability, accumulate AGEs more slowly and preserve tissue function across multiple organ systems. Continuous glucose monitoring (CGM) studies have revealed that even individuals classified as metabolically healthy by conventional criteria (normal fasting glucose and HbA1c) can experience significant glucose excursions that traditional point-in-time measurements fail to capture, and these occult glucose fluctuations correlate with accelerated biological aging markers. Compellingly, ambulant 24-hour glucose rhythms obtained through CGM correlate with both calendar age and biological age markers in apparently healthy populations, with glucose variability parameters showing particular sensitivity to aging status [26,27,28,29].

The concept of metabolic flexibility, defined as the organism’s capacity to efficiently switch between glucose and fat oxidation in response to nutrient availability and energetic demands, emerges as a critical determinant of aging trajectories. Metabolic flexibility declines with advancing age, with older adults showing suppressed glucose kinetics (reduced rates of glucose appearance, disposal, and metabolic clearance) even in the absence of overt metabolic disease. This age-related loss of metabolic flexibility appears driven by decreased mitochondrial β-oxidation pathway adaptability, reduced insulin sensitivity in skeletal muscle, and impaired coordination between nutrient sensing and substrate utilization. Studies using glucose and lactate tracers combined with indirect calorimetry during oral glucose tolerance tests reveal that glucose kinetic alterations in healthy older individuals are not adequately reflected by respiratory exchange ratio (RER) measurements alone, indicating that subtle but functionally significant metabolic inflexibility precedes conventional diagnostic detection. Individuals who successfully maintain metabolic flexibility into later decades, characterized by preserved capacity for rapid fuel switching, efficient lipid oxidation during fasting states, and appropriate glucose utilization following meals, typically exhibit slower biological aging across multiple biomarker domains and, notably, often appear younger than chronologically matched peers with metabolic rigidity [30,31,32].

Strikingly, perceived facial age, the age individuals appear to observers, correlates significantly with biochemical indicators of glucose metabolism. A 2022 study examining perceived age and biochemical parameters found that glucose levels were linked with perceived age, suggesting that glucose control influences not merely internal metabolic health but also external visible aging manifestations. This association likely operates through multiple mechanisms including AGE-mediated dermal changes, inflammatory pathway activation, oxidative stress generation, and microvascular dysfunction that collectively impair skin structure, nutrient delivery, and repair capacity [33].

Mitochondrial Health and Energy Metabolism

Mitochondria, the double-membraned organelles responsible for cellular ATP generation through oxidative phosphorylation. occupy a central position in aging biology, serving simultaneously as energy producers, metabolic signaling hubs, and sources of damaging reactive oxygen species (ROS). Mitochondrial function progressively declines with advancing age across tissues, characterized by reduced respiratory chain efficiency, decreased ATP production capacity, impaired calcium buffering, and paradoxically increased ROS generation despite lower overall metabolic rate. This age-related mitochondrial dysfunction results from cumulative damage to mitochondrial proteins, lipids, and DNA; impaired mitochondrial biogenesis; defective quality control through mitophagy; and altered mitochondrial dynamics (fusion and fission balance). The mitochondrial free radical theory of aging posits that ROS generated as unavoidable byproducts of electron transport chain activity cause progressive oxidative damage to mitochondrial components, creating a vicious cycle wherein damaged mitochondria produce even more ROS, accelerating cellular aging [34,35].

However, this trajectory is far from uniform across individuals, and mounting evidence indicates that those who appear younger and exhibit slower biological aging maintain superior mitochondrial health through enhanced quality control mechanisms. Age-related increases in mitochondrial ROS (mtROS) associate strongly with mitochondrial oxidative damage accumulation, altered membrane potential, and protein carbonyl formation, yet pharmacological attenuation of mtROS using mitochondria-targeted antioxidants (such as SS-31 peptide) can prevent age-related mitochondrial oxidative damage and critically, improve mitophagic potential. Mitophagy, the selective autophagic degradation of damaged or dysfunctional mitochondria, represents a crucial quality control mechanism that becomes impaired with aging, allowing non-functional mitochondria to accumulate and compromise cellular energetics. Studies in aged mice demonstrate that altered mitochondrial redox state is associated with defective mitophagy, and restoration of mitochondrial redox homeostasis through targeted antioxidant treatment improves mitophagy and partially prevents the decline in mitochondrial DNA abundance and biogenesis that characterize muscle aging. Individuals who successfully maintain youthful phenotypes often exhibit preserved mitochondrial density, superior oxidative phosphorylation capacity, efficient mitochondrial quality control through active mitophagy, and favourable mitochondrial dynamics that collectively preserve cellular bioenergetics [34,35].

Figure 3. Signaling pathways regulating mitiochondrial function [35]

A growing arsenal of interventions demonstrates capacity to enhance mitochondrial function and potentially slow biological aging through this mechanism. Regular exercise, particularly aerobic endurance training and high-intensity interval training represents perhaps the most potent stimulus for mitochondrial biogenesis, increasing mitochondrial density, improving respiratory chain efficiency, and enhancing mitophagic clearance of damaged organelles. Caloric restriction and intermittent fasting protocols activate similar pathways through AMPK and SIRT1 signalling, promoting mitochondrial biogenesis while enhancing quality control. Specific nutritional compounds show promise for mitochondrial support: coenzyme Q10 (CoQ10) functions as an electron carrier in the respiratory chain and antioxidant that may partially compensate for age-related CoQ10 decline; NAD+ precursors including nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) address age-related NAD+ depletion that impairs mitochondrial function and DNA repair; and urolithin A (UA), a gut microbiome-derived metabolite from ellagitannins in pomegranates and berries, specifically enhances mitophagy and mitochondrial function. Recent comparative studies reveal that UA and NR differentially regulate cellular pathways, with both compounds reducing DNA damage-induced cellular senescence and improving mitochondrial respiration, but exhibiting distinct effects on ROS production, glycolytic function, and inflammatory signalling. These interventions may prove particularly valuable for individuals with baseline mitochondrial dysfunction or those experiencing accelerated age-related mitochondrial decline [34,36,37].

Emerging research has identified mitochondrial DNA (mtDNA) heteroplasmy, the coexistence of both wild-type and mutant mtDNA molecules within cells as an important correlate of age-related phenotypes and biological aging rates. Unlike nuclear DNA, mtDNA exists in hundreds to thousands of copies per cell, and somatic mtDNA mutations accumulate progressively with age through both replication errors and oxidative damage. The proportion of mutated mtDNA (heteroplasmy level) rather than mere presence of mutations appears critical for phenotypic consequences, with high heteroplasmy levels inducing dysfunction while low levels remain compensated by wild-type copies. Groundbreaking 2024 research using induced pluripotent stem cells (iPSCs) with defined high-level mtDNA deletion mutations demonstrated that increased mitochondrial mutation heteroplasmy induces transcriptomic and metabolic shifts consistent with cellular aging, including altered lipid metabolism and significantly increased epigenetic age as measured by Horvath DNA methylation clocks. Longitudinal studies reveal that both mutation accumulation and selective pressures affect blood mtDNA sequence composition over the human lifespan, with evidence for both neutral drift and purifying selection operating on mitochondrial genetic variation. Lower mtDNA mutation burden associates with preserved youthfulness across multiple aging metrics, suggesting that mitochondrial genetic integrity represents an underappreciated determinant of biological aging rates. While mitochondrial mutation accumulation was historically considered irreversible, evidence that mitophagy can selectively degrade mitochondria with high mutation loads offers hope that interventions enhancing mitophagic clearance might reduce overall cellular heteroplasmy levels and ameliorate aging phenotypes [38,39].

Lifestyle Interventions and Youth Preservation

Dietary Patterns and Nutritional Factors

A growing body of evidence indicates that specific dietary patterns are consistently associated with decelerated biological aging and epigenetic age attenuation. Mediterranean-style dietary patterns, characterized by high intake of vegetables, fruits, whole grains, legumes, olive oil, nuts, and fish, and relatively low consumption of red and processed meat, are repeatedly linked with slower progression of aging phenotypes and reduced incidence of age-related diseases. In the NU-AGE trial, a one-year Mediterranean-like dietary intervention in older adults (≥65 years) was associated with negative age acceleration values on DNA methylation clocks, indicative of epigenetic rejuvenation, particularly in individuals who were biologically older at baseline. Higher adherence scores to the Mediterranean diet correlated with lower epigenetic age acceleration, supporting the concept that this pattern can slow epigenetic aging beyond its well-established cardiometabolic benefits. Mechanistically, Mediterranean diets are rich in polyphenols, omega-3 fatty acids, and fermentable fibers that collectively reduce oxidative stress and systemic inflammation, improve endothelial function, and support a diverse, metabolically favourables gut microbiome, while their relatively low glycemic load helps limit postprandial glucose excursions and thereby reduces AGE formation [40,41,42,43,44].

Beyond overall dietary pattern, energy intake itself exerts profound effects on longevity pathways. Caloric restriction (CR), typically defined as a 20–40% reduction in caloric intake without malnutrition remains the most robust, reproducible non-genetic intervention for extending lifespan and health span across multiple model organisms. Mechanistically, CR decreases activity of the mechanistic target of rapamycin (mTOR) pathway while simultaneously activating AMP-activated protein kinase (AMPK) and sirtuin 1 (SIRT1), largely through shifts in the AMP/ATP and NAD+/NADH ratios. Activation of AMPK and SIRT1 and inhibition of mTOR converge on peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), enhancing mitochondrial biogenesis, improving metabolic efficiency, and promoting cellular stress resistance, while reducing genomic instability, proteostatic imbalance, and mitochondrial dysfunction, all central hallmarks of aging. Even modest caloric reductions (10–15%) in humans, when carefully implemented to avoid micronutrient deficiencies, appear sufficient to produce favourable changes in cardiometabolic risk factors and are increasingly associated with beneficial shifts in biological aging markers. Time-restricted eating (TRE), a form of intermittent fasting in which daily caloric intake is confined to a 6–10-hour window (for example, 16:8), enhances metabolic flexibility, promotes autophagy during extended fasting intervals, and reinforces circadian rhythm synchronization by consolidating feeding into the biologically appropriate phase. Early TRE, aligning food intake with daytime activity, improves insulin sensitivity, reduces blood pressure, and lowers cardiometabolic risk markers even without weight loss, illustrating that temporal distribution of calories can influence aging-related pathways independently of total caloric load [31,45,46,47].

Micronutrient adequacy represents an often underestimated but crucial determinant of biological age. Vitamin D deficiency has been associated with shorter leukocyte telomere length, higher inflammatory burden, and increased all-cause mortality, suggesting that sufficient vitamin D status supports genomic stability and immunoregulation relevant to aging trajectories. Trace elements such as selenium and zinc serve as essential cofactors for antioxidant enzymes including glutathione peroxidases and superoxide dismutase; inadequate intake impairs redox homeostasis and increases vulnerability to oxidative damage, accelerating multiple aging hallmarks. B-vitamins, particularly folate, vitamin B6, and vitamin B12, are central to one-carbon metabolism and methyl-donor availability, directly influencing DNA methylation patterns that underlie epigenetic clock measures of biological age. Observational data indicate that diets richer in methyl-donor nutrients and methylation-supportive phytochemicals (so-called “methyl adaptogens”) associate with lower epigenetic age independent of other dietary quality indices, emphasizing the importance of micronutrient sufficiency and methylation-supportive nutrition in biological age modulation [35,41,48].

Exercise and Physical Activity

Regular physical activity is one of the most powerful non-pharmacologic interventions for slowing biological aging, exerting systemic benefits across cardiovascular, metabolic, musculoskeletal, neurocognitive, and immune domains. Accumulating evidence shows that habitual exercise favourably influences telomere biology, with endurance-trained athletes and physically active individuals exhibiting longer leukocyte telomere length and higher telomerase activity than sedentary counterparts. Mechanistically, physical activity attenuates excessive ROS generation, enhances endogenous antioxidant defenses (upregulating superoxide dismutase and catalase), and reduces chronic low-grade inflammation, all key drivers of telomere shortening and cellular senescence. Exercise also promotes mitochondrial biogenesis and turnover via PGC-1α activation, improves endothelial function, enhances insulin sensitivity, and maintains skeletal muscle mass and bone mineral density, thereby mitigating multiple hallmarks of aging in parallel. A 2025 analysis of physical activity and DNA methylation predicted epigenetic clocks in a large US population sample demonstrated a robust inverse association between physical activity levels and eight different DNAm-predicted ages, even after adjustment for confounders such as sex, BMI, smoking, and alcohol consumption. The strongest effects were observed for SkinBloodAge and LinAge clocks, suggesting that physical activity exerts particularly pronounced influence on epigenetic mechanisms relevant to both systemic and cutaneous aging [49,50].

Within the spectrum of exercise modalities, high-intensity interval training (HIIT) appears particularly effective for biological age reduction through hormetic mechanisms. Brief, repeated bouts of high-intensity effort followed by recovery periods produce controlled physiological stress that activates cellular repair pathways, upregulates antioxidant defense systems, and enhances mitochondrial function more efficiently than equivalent-volume moderate-intensity continuous training in some contexts. Elite and masters athletes, individuals maintaining high training volumes and intensities into midlife and beyond often display biological ages substantially younger than their chronological ages, with some cohorts showing telomeric and cardiometabolic profiles resembling those of individuals 10–20 years younger. While genetic self-selection likely contributes to these findings, longitudinal data support a causal role of sustained training in preserving telomere length and attenuating age-related physiological decline. Beyond structured exercise, non-exercise activity thermogenesis (NEAT), calories expended through daily activities such as walking, standing, manual tasks, and household chores contributes significantly to total daily energy expenditure and appears particularly important for aging trajectories in real-world settings. Populations residing in so-called Blue Zones, noted for high concentrations of centenarians, typically do not engage in formal exercise regimens but instead accumulate high levels of low-to-moderate intensity movement throughout daily life, including walking, gardening, and manual labor, illustrating that continuous, integrated physical activity can support exceptional longevity and preserved function [51,52].

Sleep Quality and Circadian Alignment

Sleep represents a fundamental yet frequently underappreciated pillar of biological age regulation. During sleep, especially deep slow-wave sleep, the glymphatic system clears metabolic waste products and neurotoxic proteins from the brain interstitial space, cellular repair and autophagic processes are upregulated, and hormonal rhythms, including growth hormone, cortisol, and melatonin reset in a coordinated fashion. Chronic sleep deprivation or poor sleep quality disrupts these restorative processes, leading to increased systemic inflammation, impaired glucose metabolism, dysregulated appetite hormones, and accelerated accumulation of cellular damage. Recent epigenetic research substantiates these clinical observations: a 2025 study demonstrated that older adults with chronic insomnia exhibit significantly accelerated GrimAge and SkinBloodClock epigenetic ages, accompanied by reduced DNA methylation–estimated telomere length (DNAmTL) and global hypomethylation patterns enriched for proteostasis and oxidative stress pathways. These findings indicate that sleep disturbance directly accelerates molecular aging via epigenetic modifications and telomere-related mechanisms, rather than merely correlating with aging through behavioural or comorbid confounders [31,53].

Sleep quality and architecture appear to matter at least as much as total duration. Deep (slow-wave) sleep and REM sleep serve distinct, complementary restorative roles, and individuals who maintain robust sleep architecture into later life demonstrate better cognitive performance, preserved metabolic health, and often more youthful appearance compared with age-matched peers with fragmented or shallow sleep. Emerging data from consumer-grade and research-grade sleep tracking devices show that higher sleep efficiency (proportion of time in bed spent asleep), lower nocturnal fragmentation, and consistent sleep timing across nights correlate with more favourable biological age markers, including slower epigenetic age acceleration and better cardiometabolic profiles. Circadian alignment, the synchronization of behavioural rhythms, especially sleep-wake cycles and feeding times, with endogenous circadian clocks and environmental light-dark cycles further optimizes aging trajectories. Circadian disruption, as seen in shift work, social jet lag, and irregular schedules, is associated with increased risk of obesity, type 2 diabetes, cardiovascular disease, and certain cancers, all of which reflect accelerated biological aging. At the molecular level, misalignment between central (suprachiasmatic nucleus) and peripheral clocks dampens amplitude and coherence of circadian transcriptional programs, impairs metabolic regulation, and interferes with coordinated cellular repair, collectively promoting aging-related dysfunction [31,45,46].

Stress Management and Psychological Resilience

Chronic psychological stress constitutes a powerful accelerator of biological aging, acting through sustained hypothalamic–pituitary–adrenal (HPA) axis activation, elevated cortisol exposure, enhanced oxidative stress, low-grade inflammation, and direct effects on telomere dynamics. Numerous observational studies have linked perceived stress, caregiving burden, and trauma exposure with shorter leukocyte telomere length and increased risk of age-related diseases, while experimental paradigms demonstrate that acute and chronic stressors can rapidly alter epigenetic marks on genes involved in stress response and inflammation. Conversely, psychological resilience, the capacity to adapt positively to adversity, and effective stress management associate with slower aging rates and reduced incidence of chronic disease. Mind-body practices including mindfulness meditation, yoga, and controlled breathwork offer accessible tools for modulating the stress response and appear to exert measurable effects on molecular aging markers. A meta-analysis of four randomized controlled trials found that mindfulness meditation led to moderate increases in telomerase activity in peripheral blood mononuclear cells (effect size d=0.46), suggesting improved capacity for telomere maintenance and potential slowing of cellular aging. These practices likely act through multiple converging mechanisms, including downregulation of HPA axis hyperactivity, enhancement of parasympathetic (vagal) tone, reduction of pro-inflammatory cytokine levels, and favourable modulation of gene expression profiles related to inflammation and cellular stress responses [31,51,54].

Social connection and sense of purpose represent critical yet often under-recognized longevity determinants. A landmark meta-analysis of 148 studies involving more than 308,000 participants demonstrated that strong social relationships are associated with a 50% increased odds of survival across all causes of death, an effect size comparable to smoking cessation and greater than benefits from physical activity, weight loss, or blood pressure control. Both the quantity and quality of social connections matter: individuals with broader social networks and those who feel supported, understood, and valued experience substantially reduced mortality risk, while social isolation and loneliness emerge as independent risk factors comparable to traditional biomedical risk factors. These findings suggest that social relationships influence fundamental biological processes rather than merely buffering specific disease pathways. Proposed mechanisms include reduced chronic stress burden, lower HPA axis activation, enhanced immune competence, healthier behavioural patterns (e.g., better adherence to medical advice and lifestyle recommendations), and possibly direct effects on inflammatory and neuroendocrine signalling. Similarly, a strong sense of purpose in life has been linked to reduced risk of cognitive decline, cardiovascular events, and all-cause mortality in longitudinal cohorts, indicating that psychological and existential factors materially shape aging trajectories. Together, this evidence supports an integrative view of youth preservation in which dietary pattern, physical activity, sleep quality, circadian alignment, stress management, and social connection function as mutually reinforcing pillars that collectively determine biological aging rate and the likelihood of maintaining youthful appearance and function into later life [51].

Dermatological and Aesthetic Factors

Skin Care and Photoprotection

Extrinsic skin aging, driven predominantly by chronic ultraviolet (UV) exposure, accounts for an estimated 80% of visible facial aging in fair-skinned populations, making photoprotection a central determinant of cutaneous youthfulness. UV radiation penetrates the epidermis and dermis where it generates reactive oxygen species that damage nuclear and mitochondrial DNA, activate matrix metalloproteinases, and accelerate degradation of collagen and elastin, ultimately inducing cellular senescence in dermal fibroblasts and producing the clinical phenotype of photoaged skin, wrinkling, laxity, dyspigmentation, and coarse texture. Individuals who appear substantially younger than their chronological age almost invariably report long-term photoprotective behaviours, including daily broad-spectrum sunscreen use, shade seeking, and avoidance of tanning, underscoring the preventable nature of much visible skin aging [55,56,57,58,59].

Evidence-based topical skincare targets multiple aging mechanisms simultaneously. Retinoids (topical tretinoin, retinaldehyde, retinol) remain the gold-standard topical anti-aging agents; they bind nuclear retinoic acid receptors, upregulate dermal fibroblast collagen synthesis, downregulate UV-induced MMP expression, normalize keratinocyte differentiation, and increase epidermal thickness, leading to clinically meaningful reductions in fine wrinkles, roughness, and mottled hyperpigmentation. Antioxidants such as vitamin C and vitamin E provide complementary photoprotection by scavenging ROS, stabilizing collagen, and, in the case of vitamin C, directly stimulating collagen production and improving dyschromia, while niacinamide (vitamin B3) supports barrier function, reduces inflammation, improves texture, and may modestly enhance collagen synthesis. Alpha-hydroxy acids (e.g., glycolic and lactic acid) promote controlled exfoliation of the stratum corneum, increase epidermal turnover, and induce dermal remodelling with increased glycosaminoglycans and collagen content, thereby improving skin smoothness and luminosity when used appropriately. Importantly, skin appearance frequently mirrors systemic health: dermal microcirculation, collagen integrity, barrier function, and sebum production are influenced by endocrine status (e.g., thyroid, sex steroids), nutritional adequacy (protein and micronutrients), and metabolic health (insulin resistance, glycation burden), so youthful-appearing skin often reflects broader biological preservation rather than purely cosmetic intervention [55,56,60,61].

Hormonal Optimization

Sex steroid hormones exert profound effects on skin biology and visible aging. Estrogens act on keratinocytes, fibroblasts, melanocytes, hair follicles, and sebaceous glands via estrogen receptors, promoting collagen synthesis, glycosaminoglycan and hyaluronic acid production, epidermal proliferation, vascularization, and sebum regulation. Following menopause, estrogen deficiency precipitates a rapid decline in skin quality: collagen content decreases by roughly 2% per year, with up to 30% loss of types I and III collagen in the first five years, accompanied by thinning of the dermis and epidermis, reduced elasticity, dryness, impaired wound healing, and accelerated wrinkle formation. Systemic or topical estrogen replacement, when appropriately indicated and individualized, can partially reverse these changes by increasing epidermal thickness, dermal collagen content, hydration, and elasticity, leading to clinically observable improvements in skin texture and wrinkle depth; however, such benefits must be balanced against systemic risks and delivered within a comprehensive risk–benefit framework. In men, physiologic testosterone supports muscle mass, bone density, sebum production, and dermal thickness, while age-related androgen decline contributes to sarcopenia, changes in facial structure, and skin thinning, though the aesthetics, longevity trade-offs of androgen supplementation remain complex and context dependent [63,64,65].

Beyond classic sex steroids, the growth hormone (GH), insulin-like growth factor 1 (IGF-1) axis illustrates the growth–aging paradox. Adequate GH/IGF-1 signalling is essential for tissue maintenance, dermal thickness, and hair growth, yet chronic elevation of this pathway is associated with increased oxidative stress, higher cell proliferation rates, and accelerated aging and cancer risk, whereas mild attenuation of IGF-1 signalling is repeatedly linked with exceptional longevity and reduced age-related disease burden in centenarians and caloric-restricted mammals. From a longevity perspective, an optimal strategy likely emphasizes physiologic, pulsatile GH/IGF-1 secretion driven by lifestyle factors, restorative sleep, regular exercise, and intermittent fasting, rather than chronic pharmacologic stimulation, aiming to maintain sufficient trophic support for tissue integrity while avoiding sustained pro-growth signalling that could accelerate systemic aging. In clinical practice, therefore, “hormonal optimization” for youth preservation increasingly prioritizes lifestyle-based support of endogenous hormone production and sensitivity, reserving hormone replacement therapy for clearly defined indications and integrating it with rigorous monitoring, photoprotection, and evidence-based topical regimens to synergistically support both visible and systemic markers of healthy aging [15,31,63,65].

Environmental and Exposome Considerations

Air Pollution and Environmental Toxins

Environmental exposures represent powerful yet often underappreciated modulators of biological aging. Ambient air pollution, particularly fine particulate matter (PM₂.₅), ozone, and polycyclic aromatic hydrocarbons (PAHs) accelerates skin and systemic aging by inducing oxidative stress, chronic inflammation, and telomere attrition. Epidemiologic and clinical studies show that higher exposure to traffic-related or biomass-derived air pollution associates with shorter leukocyte telomere length in both children and adults, supporting a direct link between polluted air and accelerated cellular aging. Dermatologic data indicate that both outdoor and indoor pollution increase facial lentigines and wrinkles, reinforcing clinical observations that urban dwellers often display more pronounced signs of extrinsic aging than rural counterparts matched for chronological age [66,67,68].

Microplastics and endocrine-disrupting chemicals (EDCs) such as bisphenol A and phthalates have emerged as additional contributors to aging biology. These contaminants accumulate in tissues, generate excess reactive oxygen species, impair antioxidant defenses, disrupt mitochondrial function, and interfere with estrogen, androgen, thyroid, and glucocorticoid receptor signalling, collectively driving oxidative stress, hormonal imbalance, and genomic instability. Recent reviews highlight oxidative stress as the central mechanism linking microplastic and EDC exposure to systemic toxicity, with documented effects on metabolic, reproductive, cardiovascular, and neurobiological outcomes, pathways closely tied to age-related disease and functional decline. Heavy metals such as lead, cadmium, and mercury further contribute to accelerated aging by inducing oxidative damage, impairing the autophagy–lysosomal pathway, and disrupting neuronal and systemic homeostasis. These metals generate excessive ROS and deplete endogenous antioxidant systems (e.g., glutathione), leading to lipid peroxidation, DNA damage, and protein dysfunction that cumulatively promote neurodegeneration and chronic disease. While robust human interventional data remain limited, supporting endogenous detoxification pathways via adequate hydration, high-fiber diets, cruciferous vegetables (for phase II conjugation support), and targeted use of glutathione precursors or chelating agents under medical supervision is physiologically plausible and commonly recommended as a risk-mitigation strategy rather than a cure [31,66,69,70,71].

Alcohol, Smoking, and Substance Effects

Tobacco smoking is arguably the single most potent modifiable behavioural driver of both visible and biological aging. Cigarette smoke delivers a high burden of free radicals and pro-oxidant compounds that induce oxidative DNA damage, promote chronic inflammation, impair microvascular function, and upregulate matrix metalloproteinases that degrade dermal collagen and elastin, producing the characteristic phenotype of “smoker’s face.” A systematic review of over 20 studies confirms that ever-smokers have significantly shorter leukocyte telomere length than never-smokers, with dose–response analyses demonstrating an inverse relationship between cumulative pack-years and telomere length, suggesting that smoking directly accelerates telomere erosion and cellular senescence. Skin-based studies further show that higher pack-year exposure correlates with reduced expression of human telomerase reverse transcriptase (hTERT) in the epidermis and dermis, indicating impaired telomere maintenance and providing a mechanistic bridge between smoking, telomere biology, and cutaneous aging. Crucially, observational data and clinical experience indicate that smoking cessation leads to partial recovery of vascular function and noticeable improvements in skin quality within a few years, consistent with deceleration and to some extend reversal of biological age markers once the ongoing toxic exposure is removed [56,72,73].

The relationship between alcohol consumption and aging is more nuanced and appears J-shaped in many cohorts. A large prospective study of older adults found that lifetime alcohol intake displayed a J-shaped association with combined risk of cancer and all-cause mortality: intakes between 1 and <5 drinks per week were associated with the lowest combined risk, whereas both abstinence and higher consumption levels were linked with increased risk. However, when cancer risk is considered separately, even light-to-moderate alcohol use is associated with elevated risk for several malignancies, and alcohol also impairs sleep quality and promotes atrial arrhythmias, both of which indirectly influence biological aging. These complexities underscore that the “optimal” alcohol pattern is highly individual and dependent on genetic factors (e.g., ALDH2 variants affecting acetaldehyde metabolism), comorbid conditions, and personal risk tolerance. From a pure longevity and health span perspective, minimizing or avoiding alcohol, while ensuring that abstinence is not a surrogate for underlying ill health is generally the most conservative strategy, but decisions must be tailored to the clinical and psychosocial context [74,75].

Emerging Biohacking and Longevity Interventions

Senolytic Therapies and Cellular Rejuvenation

Cellular senescence, characterized by irreversible cell-cycle arrest and acquisition of a pro-inflammatory senescence-associated secretory phenotype (SASP), contributes causally to multiple age-related pathologies including osteoarthritis, atherosclerosis, neurodegeneration, and frailty. Senolytic drugs are designed to selectively induce apoptosis in senescent cells by targeting their pro-survival pathways, thereby reducing senescent cell burden and SASP-driven chronic inflammation without continuous exposure. Among natural senolytics, fisetin and quercetin have shown particular promise in preclinical models: fisetin emerged as the most potent senolytic among 10 flavonoids tested, reducing senescence markers in multiple tissues, restoring tissue homeostasis, decreasing age-related pathology, and extending both median and maximum lifespan in aged mice when given intermittently. Early human work remains preliminary; a longitudinal, non-randomized Phase I pilot study of dasatinib plus quercetin in older adults demonstrated complex effects, including transient increases in some first-generation epigenetic age measures and telomere shortening, highlighting both the potential and the need for caution and better biomarkers in human senolytic trials [76,77,78,79,80].

Fasting and fasting-mimicking diets (FMDs) may confer senotherapeutic effects indirectly by enhancing autophagy and cellular quality-control mechanisms. In a recent randomized pilot trial, an 8-day FMD in healthy adults significantly increased autophagic flux as measured dynamically by LC3B turnover by day 6, with elevated autophagy persisting for at least 48 hours after refeeding in the standard ProLon formulation, suggesting a transient but meaningful recalibration of cellular “cleanup” machinery toward maintenance and repair. These findings support the concept that periodic metabolic stress via extended fasting (≈3–5 days) or structured FMD cycles can promote removal of damaged organelles and macromolecules and possibly reduce senescent cell burden, although direct human evidence for senolysis remains limited and mechanistically inferred at present [76,81].

NAD+ Optimization and metabolic Modulators

Nicotinamide adenine dinucleotide (NAD⁺) is a central redox cofactor and essential substrate for sirtuins, PARPs, and other enzymes involved in DNA repair, mitochondrial function, and stress resistance. Multiple animal and human studies show that NAD⁺ levels decline with age across tissues including skin and brain, with reductions on the order of 10–25% in the human brain and up to ≈50% in adult versus newborn skin, accompanied by a shift toward a more reduced NAD⁺/NADH ratio. This decline is driven by reduced synthesis (e.g., decreased NAMPT activity), increased consumption by overactive PARPs/CD38, and chronic inflammatory signalling, collectively impairing mitochondrial bioenergetics and genomic maintenance. NAD⁺ precursors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) can raise circulating and tissue NAD⁺ levels in humans and have been associated with improvements in some metabolic parameters and mitochondrial function, but robust evidence for hard clinical endpoints or sustained biological age reversal is still emerging and remains inconclusive [82].

Other metabolic modulators investigated for geroprotective effects include metformin, rapamycin, and resveratrol. Metformin, a widely used AMPK activator and mild complex I inhibitor, has been associated observationally with reduced incidence of age-related diseases and mortality in people with type 2 diabetes, but systematic reviews indicate that its life-extending effects in animal models are inconsistent and generally modest compared with caloric restriction. Rapamycin, a selective mTORC1 inhibitor, reproduces many molecular effects of caloric restriction and reliably extends lifespan in multiple model organisms, sometimes nearly matching dietary restriction in effect size; early human trials using low, intermittent dosing regimens report improvements in some health span markers, but long-term safety and true longevity effects remain unproven. Resveratrol, a polyphenol that activates sirtuin pathways under certain conditions, shows lifespan extension primarily in metabolically stressed or high-fat-fed animals rather than in normally fed cohorts, suggesting its geroprotective effects may be context dependent. Collectively, these agents occupy a promising but still experimental space in human longevity, warranting cautious, evidence-based integration rather than routine use [47,83].

Cold Exposure and Hormetic Stress

Hormesis, the concept that low-dose, intermittent stress can provoke adaptive responses that enhance resilience underpins interest in environmental stressors as longevity tools. Cold exposure via cold-water immersion, cold showers, or controlled ambient cold activates brown adipose tissue (BAT) and beige adipocytes, increasing non-shivering thermogenesis, glucose uptake, and fatty acid oxidation while promoting favourable changes in whole-body metabolic flexibility. Multi-tissue omics analyses in cold-adapted mice demonstrate cross-tissue metabolic rewiring, including increased glucose flux into the pentose phosphate pathway in BAT to support superoxide production and UCP1-mediated thermogenesis, illustrating that cold triggers complex networks beyond simple calorie burning. These adaptive responses enhanced mitochondrial biogenesis, improved insulin sensitivity, and upregulated antioxidant defenses are mechanistically aligned with slower biological aging, but rigorous human data specifically linking routine cold exposure to validated aging biomarkers remain limited [84].

In contrast, heat stress via sauna bathing has more extensive human epidemiologic support. Prospective data from the Kuopio Ischemic Heart Disease cohort (n≈2,300 Finnish men) showed that higher frequency of sauna bathing was strongly associated with reduced risk of sudden cardiac death, fatal coronary heart disease, fatal cardiovascular disease, and all-cause mortality over ≈20 years of follow-up, with men using the sauna 4–7 times per week experiencing roughly 40–60% lower risk of these outcomes compared with once-weekly users. Subsequent analyses indicate that frequent sauna bathing may attenuate the excess mortality risk associated with elevated inflammatory markers (e.g., high-sensitivity CRP), suggesting that heat exposure interacts beneficially with inflammatory pathways. Mechanistically, repeated sauna use induces cardiovascular conditioning (increased heart rate and stroke volume, improved vascular function), upregulates heat shock proteins that stabilize proteins and support proteostasis, and enhances autonomic balance, all of which align with reduced biological aging and improved health span. Together, these emerging interventions, senolytics, fasting/FMDs, NAD⁺ boosters, metabolic modulators, and thermal hormesis, represent a rapidly evolving frontier in biohacking; yet for now, they are best viewed as adjuncts layered onto foundational lifestyle behaviours rather than substitutes for them, pending stronger long-term human data [85,86].

Integrative Framework and Personalization

Multi-Omic Assessment and Precision Longevity

The emerging paradigm in longevity medicine is shifting from single-marker screening toward integrated, multi-omic characterization of biological aging at the individual level. Epigenomic, transcriptomic, proteomic, metabolomic, and microbiomic datasets can be combined with machine-learning methods to construct “aging clocks” that often outperform chronological age in predicting morbidity, mortality, and functional decline. Epigenetic clocks such as DNAm PhenoAge and GrimAge, which estimate age from DNA methylation patterns at selected CpG sites, are currently the most mature tools for quantifying biological age and age acceleration and are increasingly used as endpoints in lifestyle and pharmacologic intervention trials. Telomere length and integrity remain complementary markers of replicative history and genomic stability, while multi-omic clocks based on circulating proteins and metabolites capture downstream functional consequences of genetic regulation and environmental exposures, including diet and lifestyle [87,88,89,90].

Alongside these molecular clocks, advanced biomarker panels such as IgG glycosylation profiles (commercialized as GlycanAge) provide immune-centered measures of biological age by quantifying age- and inflammation-related changes in immunoglobulin G glycan patterns, which are tightly linked to inflammaging and immune system remodelling. Comprehensive assessment of biological aging in a precision-longevity framework therefore typically incorporates:

Epigenetic clocks (e.g., PhenoAge, GrimAge)
Leukocyte telomere length or DNAm-estimated telomere length
Inflammatory and glycan-based biomarkers
Metabolic flexibility testing using continuous glucose monitoring, oral or mixed-meal tolerance tests, and, where available, indirect calorimetry or metabolic chambers
Composition (DXA or bioimpedance) and functional capacity measures (VO₂max, grip strength, gait speed, balance)
Microbiome diversity and compositional analysis to capture gut–immune–metabolic cross-talk.

Integrating these data layers enables identification of individual rate-limiting nodes in the aging network such as excessive inflammatory signalling, impaired glucose handling, mitochondrial dysfunction, or immune dysregulation and allows clinicians to prioritize targeted interventions rather than applying generic “one-size-fits-all” protocols [87,91,92,93].

Synergistic Intervention Stacking

Converging evidence indicates that the greatest deceleration of biological aging occurs not from single isolated interventions but from strategic combinations of lifestyle and, where appropriate, adjunctive therapies that act through overlapping and synergistic mechanisms. In a secondary analysis of a 12‑month randomized trial in older adults with obesity, both calorie restriction alone and calorie restriction combined with exercise significantly improved multiple biological age indices (Klemera–Doubal biological age, Homeostatic Dysregulation, Healthy Aging Index), whereas exercise without dietary modification did not meaningfully alter biological age over the same period; notably, the diet–exercise combination produced the most favourable functional aging profile, underscoring the importance of multimodal intervention. Likewise, observational studies consistently show that adherence to a greater number of health-promoting behaviours, like nonsmoking, limited alcohol intake, daily consumption of fruits and vegetables, regular physical activity, good sleep habits, and maintenance of healthy body composition is associated with slower biological aging across frailty indices, clinical biomarker–based ages, and epigenetic clocks [31,94].

An evidence-based longevity protocol therefore typically “stacks” interventions such as:

Nutritional optimization via a Mediterranean-style dietary pattern with adequate protein and micronutrients and tight glycemic control;
Time-restricted eating (commonly 16:8 or 14:10) aligned with circadian rhythms;
Regular exercise combining resistance training, high-intensity interval training, and lower-intensity zone 2 aerobic work;
Sleep optimization targeting 7–9 hours of consistent, high-quality sleep with robust circadian alignment;
Structured stress-management practices (e.g., mindfulness, breathwork, yoga) and cultivation of social connection;
Environmental protection through rigorous photoprotection and air-quality management; and
Targeted supplementation informed by biomarker-identified deficiencies (e.g., vitamin D, omega‑3 fatty acids, methylation-supportive B‑vitamins).

Because many of these interventions converge on shared nodes, AMPK–mTOR–sirtuin signalling, inflammatory pathways, redox balance, mitochondrial biogenesis, and epigenetic regulation, their combined effects are likely supra-additive: the whole exceeds the sum of its parts as simultaneous pressure on multiple hallmarks of aging produces more pronounced and durable shifts in biological age than any single modality alone. This systems-level, multi-omic and multi-intervention strategy represents the core of contemporary precision longevity, aiming not merely to normalize risk factors but to reshape the overall aging trajectory in a personalized, data-driven manner [31,44,87,89].

Conclusion

The phenomenon of “looking younger” represents far more than superficial cosmetic fortune or mere aesthetic preference, it reflects biological age deceleration resulting from a convergent orchestration of favourable genetics, metabolic optimization, lifestyle practices, and environmental factors. While genetic variants in longevity-associated genes such as FOXO3, IGF-1 pathway components, and dermal structural proteins (COL1A1, MMPs) establish the initial boundaries for aging rates, emerging evidence from epigenetic clock studies and lifestyle intervention trials demonstrates remarkable plasticity in biological aging trajectories through modifiable factors. The recognition that an 8-week comprehensive lifestyle intervention can reverse biological age by over three years, as measured by DNA methylation clocks, fundamentally challenges deterministic views of aging and validates the concept that biological age is not merely an inexorable progression but a dynamic, modulable process.

The individuals who successfully maintain youthful appearance and function into later decades typically share a constellation of common characteristics that extend well beyond isolated health behaviours. These include metabolic flexibility with superior glucose regulation and efficient substrate switching between carbohydrate and fat oxidation; consistent physical activity patterns incorporating both aerobic conditioning and resistance training rather than sporadic exercise bursts; high-quality sleep architecture with adequate duration (7-9 hours) and circadian alignment synchronized to natural light-dark cycles; effective stress management through mind-body practices, social connection, and psychological resilience; robust social networks and sense of purpose that buffer against chronic stress; and importantly, minimal cumulative exposure to aging accelerators including tobacco smoking, excessive alcohol consumption, chronic psychological stress, and environmental toxins. Research examining multiple lifestyle factors collectively demonstrates that adherence to a greater number of health-promoting behaviours associates with slower biological aging across various measurement modalities, including phenotypic measures (frailty index), clinical biomarker panels (Klemera-Doubal biological age), and epigenetic clocks. Notably, a 2025 study analysing the relative contributions of individual lifestyle factors to biological aging found that adopting a healthy Mediterranean-style diet had the greatest effect on overall biological aging, contributing 24% to the overall protective effect, followed by physical activity and smoking cessation.

As longevity science advances with unprecedented velocity, the toolkit for biological age reduction continues expanding from foundational lifestyle interventions to increasingly sophisticated molecular therapeutics. Foundational interventions, such as nutritional optimization emphasizing nutrient density and glycemic control, structured exercise programs combining multiple modalities, sleep hygiene and circadian entrainment, stress management protocols, and social engagement provide the essential substrate upon which all other interventions build. Emerging therapeutics including senolytic compounds that selectively eliminate senescent cells, NAD+ precursor supplementation to restore mitochondrial function, epigenetic reprogramming approaches, and metabolic modulators (metformin, rapamycin) represent promising additions to the anti-aging arsenal, though robust human longevity data remains nascent for many of these interventions. We increasingly possess the mechanistic knowledge and measurement tools to extend health span meaningfully, the period of life spent in good health, free from significant disability.

However, a critical insight from longitudinal aging research is that sustainability and consistency trump aggressive short-term interventions in determining ultimate aging trajectories. The most successful aging phenotypes result from decades of compounding healthy behaviours that cumulatively shift biological aging rates, rather than intermittent heroic efforts followed by periods of neglect. Longitudinal studies tracking lifestyle trajectories over time reveal that consistent adherence to multiple healthy behaviours throughout middle age, when modifiable risk factors for age-related diseases exert their influence years before symptoms manifest provides far greater protective effects than late-life adoption alone. This underscores the importance of early intervention and sustained behaviour change rather than emergency responses to emerging pathology. The compounding effects of decades of favourable lifestyle choices create what has been termed “biological momentum”, a positive feedback loop where preserved function enables continued engagement in health-promoting activities, while functional decline conversely restricts activity and accelerates further deterioration.

A fundamental goal of longevity interventions should be compression of morbidity, extending health span while minimizing the duration of disability and disease preceding death, known as the “sickspan.” Recent theoretical and empirical work demonstrates that not all longevity interventions equally compress morbidity; interventions that extend lifespan by scaling the survival curve (shifting it rightward while preserving shape) tend to extend both health span and sickspan proportionally, providing minimal benefit in terms of reducing the relative burden of late-life morbidity. In contrast, interventions that steepen the survival curve, making it more rectangular and compressed, extend lifespan primarily by extending health span while compressing sickspan, thereby maximizing the proportion of life spent in good health. These curve-steepening interventions typically work by enhancing damage removal mechanisms, reducing biological noise, or raising disease and death thresholds rather than simply slowing damage production rates. This distinction has profound implications for prioritizing interventions: therapies that enhance cellular repair capacity, promote autophagy and mitophagy, reduce inflammation, and maintain homeostatic resilience may prove more valuable for health span extension than those that merely slow metabolic rate or reduce caloric intake.

Ultimately, chronological age represents merely time elapsed, an arbitrary counting of Earth’s revolutions around the sun, while biological age reflects the true functional state of our physiological systems at the cellular, tissue, organ, and organismal levels. Understanding the multifaceted determinants of biological aging, from epigenetic methylation patterns and telomere dynamics to metabolic flexibility and inflammatory status and successfully modulating these determinants through evidence-based interventions empowers us to achieve what previous generations could only imagine: not just living longer, but preserving vitality, cognitive function, physical capability, and yes, youthful appearance throughout extended lifespans. The goal is decidedly not vanity or superficial age denial, but rather sustained health span, ensuring that the years we add to life remain filled with energy, independence, purpose, and wellbeing rather than protracted decline and dependency. As we transition from reactive treatment of age-related diseases to proactive modulation of aging processes themselves, the prospect of democratizing access to these interventions holds transformative potential for individual quality of life and public health outcomes in our rapidly aging global population.

Reference

López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023 Jan 19;186(2):243–78.
Tartiere AG, Freije P, López-Otín C. The hallmarks of aging as a conceptual framework for health and longevity research. Frontiers in aging [Internet]. 2024 Jan 15;5. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10824251/
Christensen K, Thinggaard M, McGue M, Rexbye H, Hjelmborg J v B, Aviv A, et al. Perceived age as clinically useful biomarker of ageing: cohort study. BMJ. 2009 Dec 11;339(dec11 2):b5262–2.
Epigenetic Clock | UCSF SMN [Internet]. UCSF SMN. 2018 [cited 2026 Feb 7]. Available from: https://www.stressmeasurement.org/epigenetic-clock
Armstrong NJ, Mather KA, Anbupalam Thalamuthu, Wright MJ, Trollor JN, Ames D, et al. Aging, exceptional longevity and comparisons of the Hannum and Horvath epigenetic clocks. Epigenomics. 2017 May 1;9(5):689–700.
Fitzgerald KN, Hodges R, Hanes D, Stack E, Cheishvili D, Szyf M, et al. Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial. Aging [Internet]. 2021 Apr 12;13(7):9419–32. Available from: https://pubmed.ncbi.nlm.nih.gov/33844651/
News N. Diet and Lifestyle Change Reverses Aging by Three Years in Eight Weeks – Neuroscience News [Internet]. Neuroscience News. 2021 [cited 2026 Feb 7]. Available from: https://neurosciencenews.com/diet-lifestyle-biological-aging-18508/
com. New Study Shows Lifespan is 50% Genetic, Doubling Previous Estimates [Internet]. Nad.com. 2025. Available from: https://www.nad.com/news/new-study-shows-lifespan-is-50-genetic-doubling-previous-estimates
Shenhar B, Pridham G, De Oliveira TL, Raz N, Yang Y, Deelen J, et al. Heritability of intrinsic human life span is about 50% when confounding factors are addressed. Science. 2026 Jan 29;391(6784):504–10.
Donlon TA, Morris BJ, Masaki K, Chen R, Davy PMC, Kallianpur KJ, et al. FOXO3, a Resilience Gene: Impact on Lifespan, Healthspan, and Deathspan. 2022 Aug 1;77(8):1479–84. Available from: https://academic.oup.com/biomedgerontology/article/77/8/1479/6663820
Zhao Y, Liu YS. Longevity Factor FOXO3: A Key Regulator in Aging-Related Vascular Diseases. Frontiers in Cardiovascular Medicine. 2021 Dec 23;8.
Welcome To Zscaler Directory Authentication [Internet]. Nih.gov. 2026 [cited 2026 Feb 7]. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7762472/
Chen R, Morris BJ, Donlon TA, Masaki KH, Willcox DC, Davy PMC, et al. FOXO3 longevity genotype mitigates the increased mortality risk in men with a cardiometabolic disease. Aging [Internet]. 2020 Dec 1;12(23):23509–24. Available from: https://pubmed.ncbi.nlm.nih.gov/33260156/
Adler EM. Predisposed to a Long Life? Science Signaling. 2008 Mar 11;1(10).
Vitale G, Pellegrino G, Vollery M, Hofland LJ. ROLE of IGF-1 System in the Modulation of Longevity: Controversies and New Insights From a Centenarians’ Perspective. Frontiers in Endocrinology. 2019 Feb 1;10.
Geusens B, Diala Haykal. Genetic profiling and precision skin care: a review. Frontiers in Genetics [Internet]. 2025 Jun 3;16. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC12170653/
Naval J, Alonso V, Herranz MA. Genetic polymorphisms and skin aging: the identification of population genotypic groups holds potential for personalized treatments. Clinical, Cosmetic and Investigational Dermatology [Internet]. 2014 Jul 1;7:207–14. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085290/
Edyta Cichocka, Sylwia Barbara Górczyńska-Kosiorz, Niemiec P, Trautsolt W, Gumprecht J. The Impact of Selected COL1A1 and COL1A2 Gene Polymorphisms on Bone Mineral Density and the Risk of Metabolic Diseases in Postmenopausal Women. International Journal of Molecular Sciences [Internet]. 2025 May 22 [cited 2025 Oct 31];26(11):4981–1. Available from: https://www.mdpi.com/1422-0067/26/11/4981
Pittayapruek P, Meephansan J, Prapapan O, Komine M, Ohtsuki M. Role of Matrix Metalloproteinases in Photoaging and Photocarcinogenesis. International Journal of Molecular Sciences [Internet]. 2016 Jun 2;17(6):868. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926402/
Kim DJ, Iwasaki A, Chien AL, Kang S. UVB-mediated DNA damage induces matrix metalloproteinases to promote photoaging in an AhR- and SP1-dependent manner. JCI insight [Internet]. 2022 May 9;7(9). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090247
Gautieri A, Passini FS, Silván U, Guizar-Sicairos M, Carimati G, Volpi P, et al. Advanced glycation end-products: Mechanics of aged collagen from molecule to tissue. Matrix Biology. 2017 May;59:95–108.
Gkogkolou P, Böhm M. Advanced glycation end products. Dermato-Endocrinology. 2012 Jul;4(3):259–70.
Chen C, Zhang JQ, Li L, Guo M, He Y, Dong Y, et al. Advanced Glycation End Products in the Skin: Molecular Mechanisms, Methods of Measurement, and Inhibitory Pathways. Frontiers in Medicine. 2022 May 11;9.
Kris Verburgh. Causes of Aging | Advanced Glycation End Products (AGEs) & Crosslinks [Internet]. Kris Verburgh. 2023. Available from: https://www.krisverburgh.com/causes-of-aging-advanced-glycation-end-products-ages-crosslinks-and-protein-modifications
Lee JM, Veres SP. Advanced glycation end-product cross-linking inhibits biomechanical plasticity and characteristic failure morphology of native tendon. Journal of Applied Physiology [Internet]. 2019 Apr 1;126(4):832–41. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485690/
Köhlmoos A, Dittmar M. Glycemic variability and control by CGM in healthy older and young adults and their relationship with diet. Journal of the Endocrine Society [Internet]. 2025 May 8;9(7). Available from: https://doi.org/10.1210/jendso/bvaf081
Wijsman CA, van Heemst D, Hoogeveen ES, Slagboom PE, Maier AB, de Craen AJM, et al. Ambulant 24-h glucose rhythms mark calendar and biological age in apparently healthy individuals. Aging Cell [Internet]. 2013 Feb 6 [cited 2019 Dec 9];12(2):207–13. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/acel.12042
What is your bioage? • #1 Continuous Glucose Monitoring App Australia | Vively [Internet]. Vively.co.nz. 2025 [cited 2026 Feb 8]. Available from: https://www.vively.co.nz/post/what-is-your-bioage
Akintola AA, Noordam R, Jansen SW, de Craen AJ, Ballieux BE, Cobbaert CM, et al. Accuracy of Continuous Glucose Monitoring Measurements in Normo-Glycemic Individuals. Hribal ML, editor. PLOS ONE [Internet]. 2015 Oct 7 [cited 2019 Nov 3];10(10):e0139973. Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0139973
Curl CC, Leija RG, Arevalo JA, Osmond AD, Duong JJ, Huie MJ, et al. Altered glucose kinetics occurs with aging: a new outlook on metabolic flexibility. American Journal of Physiology-Endocrinology and Metabolism. 2024 Aug 1;327(2):E217–28.
Lu WH . Effect of Modifiable Lifestyle Factors on Biological Aging. The Journal of Aging Research & Lifestyle. 2024;
Zhang Y, Tang D, Zhang N, Xiang Y, Hu Y, Qian W, et al. Lifestyles and their relative contribution to biological aging across multiple-organ systems: Change analysis from the China Multi-Ethnic Cohort study. eLife. 2025 Mar 7;13.
Agnieszka Żelaźniewicz, Judyta Nowak-Kornicka, Osochocka A, Bogusław Pawłowski. Perceived facial age and biochemical indicators of glycemia in adult men and women. Scientific Reports [Internet]. 2022 Jun 16 [cited 2026 Feb 8];12(1):10149–9. Available from: https://www.nature.com/articles/s41598-022-14555-6
Sakellariou GK, Pearson T, Lightfoot AP, Nye GA, Wells N, Giakoumaki II, et al. Mitochondrial ROS regulate oxidative damage and mitophagy but not age-related muscle fiber atrophy. Scientific Reports [Internet]. 2016 Sep 29 [cited 2022 May 1];6:33944. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041117
Mammucari C, Rizzuto R. Signaling pathways in mitochondrial dysfunction and aging. Mechanisms of Ageing and Development. 2010 Jul;131(7-8):536–43.
Comparing NMN, NR, and Urolithin A for Healthy Aging – Timeline [Internet]. Timeline. 2026 [cited 2026 Feb 8]. Available from: https://www.timeline.com/blog/nmn-vs-nr-vs-ua
Madsen HB, Navarro C, Gasparini E, Park JH, Li Z, Croteau DL, et al. Urolithin A and nicotinamide riboside differentially regulate innate immune defenses and metabolism in human microglial cells. Frontiers in Aging Neuroscience [Internet]. 2024 Nov 27 [cited 2026 Feb 8];16:1503336–6. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11631940/
Vandiver AR, Torres A, Sanden A, Nguyen TL, Gasilla J, Doan MT, et al. Increased mitochondrial mutation heteroplasmy induces aging phenotypes in pluripotent stem cells and their differentiated progeny. Aging cell [Internet]. 2024 Winter;e14402. Available from: https://pubmed.ncbi.nlm.nih.gov/39680477/
Sondheimer N, Glatz CE, Tirone JE, Deardorff MA, Krieger AM, Hakonarson H. Neutral mitochondrial heteroplasmy and the influence of aging. Human Molecular Genetics. 2011 Feb 4;20(8):1653–9.
Gensous N, Garagnani P, Santoro A, Giuliani C, Ostan R, Fabbri C, et al. One-year Mediterranean diet promotes epigenetic rejuvenation with country- and sex-specific effects: a pilot study from the NU-AGE project. GeroScience. 2020 Jan 24;42(2):687–701.
Villanueva JL, Vita AA, Zwickey H, Fitzgerald K, Hodges R, Zimmerman B, et al. Dietary associations with reduced epigenetic age: a secondary data analysis of the methylation diet and lifestyle study. Aging [Internet]. 2025 Apr 17; Available from: https://www.aging-us.com/article/206240/text
Mediterranean diet high in polyphenols linked with slower biological aging | Harvard T.H. Chan School of Public Health [Internet]. Harvard T.H. Chan School of Public Health. HSPH; 2023. Available from: https://hsph.harvard.edu/news/mediterranean-diet-high-in-polyphenols-linked-with-slower-biological-aging/
Sercan Kenanoglu, Nuriye Gokce, Hilal Akalin, Mahmut Cerkez Ergoren, Beccari T, Bertelli M, et al. Implication of the Mediterranean diet on the human epigenome. PubMed [Internet]. 2022 Jun 1;63(2 Suppl 3):E44–55. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710399/
Capurso C, Bellanti F, Lo Buglio A, Vendemiale G. The Mediterranean Diet Slows Down the Progression of Aging and Helps to Prevent the Onset of Frailty: A Narrative Review. Nutrients. 2019 Dec 21;12(1):35.
Chaix A, Manoogian ENC, Melkani GC, Panda S. Time-Restricted Eating to Prevent and Manage Chronic Metabolic Diseases. Annual Review of Nutrition [Internet]. 2019 Aug 21;39(1):291–315. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6703924/
Charlot A, Hutt F, Sabatier E, Zoll J. Beneficial Effects of Early Time-Restricted Feeding on Metabolic Diseases: Importance of Aligning Food Habits with the Circadian Clock. Nutrients [Internet]. 2021 Apr 22;13(5):1405. Available from: https://dx.doi.org/10.3390%2Fnu13051405
Blagosklonny MV. Calorie restriction: Decelerating mTOR-driven aging from cells to organisms (including humans). Cell Cycle. 2010 Feb 15;9(4):683–8.
Sercan Kenanoglu, Nuriye Gokce, Hilal Akalin, Mahmut Cerkez Ergoren, Beccari T, Bertelli M, et al. Implication of the Mediterranean diet on the human epigenome. PubMed [Internet]. 2022 Jun 1;63(2 Suppl 3):E44–55. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710399/
Baliou S, Spanakis M, Apetroaei MM, Ioannou P, Fragkiadaki P, Fragkiadoulaki I, et al. The impact of exercise on telomere length dynamics: Molecular mechanisms and implications in athletes (Review). World Academy of Sciences Journal. 2025 Apr 10;7(4):1–12.
You Y, Chen Y, Ding H, Liu Q, Wang R, Xu K, et al. Relationship between physical activity and DNA methylation-predicted epigenetic clocks. npj Aging [Internet]. 2025 Apr 12;11(1). Available from: https://www.nature.com/articles/s41514-025-00217-0
Lee-Bravatti MA, O’Neill HJ, Wurth RC, Sotos-Prieto M, Gao X, Falcon LM, et al. Lifestyle Behavioral Factors and Integrative Successful Aging Among Puerto Ricans Living in the Mainland United States. Newman AB, editor. The Journals of Gerontology: Series A. 2020 Oct 12;76(6):1108–16.
Baliou S, Spanakis M, Apetroaei MM, Ioannou P, Fragkiadaki P, Fragkiadoulaki I, et al. The impact of exercise on telomere length dynamics: Molecular mechanisms and implications in athletes (Review). World Academy of Sciences Journal. 2025 Apr 10;7(4):1–12.
Rivero-Segura NA, Cuartas JDR, Garcia-delaTorre P, Sanchez-Garcia S, Ramirez-Aldana R, Gomez-Verjan JC. Insomnia accelerates the epigenetic clocks in older adults. GeroScience. 2025 Mar 18;
Schutte NS, Malouff JM. A meta-analytic review of the effects of mindfulness meditation on telomerase activity. Psychoneuroendocrinology [Internet]. 2014 Apr;42:45–8. Available from: https://www.sciencedirect.com/science/article/pii/S0306453013004538
Zhang S, Duan E. Fighting against Skin Aging. Cell Transplantation. 2018 Apr 25;27(5):729–38.
Ganceviciene R, Liakou AI, Theodoridis A, Makrantonaki E, Zouboulis CC. Skin anti-aging strategies. Dermato-Endocrinology [Internet]. 2012 Jul 1;4(3):308–19. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583892/
Tsatsou F, Trakatelli M, Patsatsi A, Kalokasidis K, Sotiriadis D. Extrinsic aging. Dermato-endocrinology [Internet]. 2012 Jul 1;4(3):285–97. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583890/
Kammeyer A, Luiten RM. Oxidation events and skin aging. Ageing Research Reviews. 2015 May;21:16–29.
Flament F, Bazin R, Rubert V, Simonpietri E, Piot B, Laquieze S. Effect of the sun on visible clinical signs of aging in Caucasian skin. Clinical, Cosmetic and Investigational Dermatology [Internet]. 2013 Sep;6:221. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790843/
Zasada M, Budzisz E. Retinoids: active molecules influencing skin structure formation in cosmetic and dermatological treatments. Advances in Dermatology and Allergology [Internet]. 2019 Aug;36(4):392–7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791161/
Bezaleel Mambwe, Mellody KT, Kiss O, O’Connor C, Bell M, Rachel, et al. Cosmetic retinoid use in photoaged skin: A review of the compounds, their use and mechanisms of action. International Journal of Cosmetic Science. 2024 Aug 11;
Ruiz CT. Estrogen, aging skin, and HRT: New evidence for restoring skin health and patient well-being in menopause [Internet]. Substack.com. Women in Dermatology; 2025 [cited 2026 Feb 9]. Available from: https://womeninderm.substack.com/p/estrogen-aging-skin-and-hrt-new-evidence
Thornton MJ. Estrogens and aging skin. Dermato-endocrinology [Internet]. 2013 Apr 1;5(2):264–70. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772914/
Vitale G, Pellegrino G, Vollery M, Hofland LJ. ROLE of IGF-1 System in the Modulation of Longevity: Controversies and New Insights From a Centenarians’ Perspective. Frontiers in Endocrinology. 2019 Feb 1;10
Feldman S. Hormone Replacement Therapy (HRT) & Skin Aging [Internet]. Dr. Zenovia. 2021 [cited 2026 Feb 9]. Available from: https://drzenovia.com/blogs/skin-journal/hormone-replacement-therapy-hrt-skin-aging
Lee EY, Lin J, Noth EM, Hammond SK, Nadeau KC, Eisen EA, et al. Traffic-Related Air Pollution and Telomere Length in Children and Adolescents Living in Fresno, CA. Journal of Occupational and Environmental Medicine. 2017 May;59(5):446–52.
Zhao B, Vo HQ, Johnston FH, Negishi K. Air pollution and telomere length: a systematic review of 12,058 subjects. Cardiovascular Diagnosis and Therapy. 2018 Aug;8(4):480–92.
Schmidt CW. Telomere Length and Air Pollution: Observations in Women Who Use Biomass Cookstoves. Environmental Health Perspectives. 2020 Mar;128(3):034005.
Kovacs K, Bodis J, Vass RA. Microplastics, Endocrine Disruptors, and Oxidative Stress: Mechanisms and Health Implications. International Journal of Molecular Sciences [Internet]. 2025 Dec 30;27(1):399–9. Available from: https://www.mdpi.com/1422-0067/27/1/399?
Kornelia Kadac-Czapska, Justyna Ośko, Knez E, Małgorzata Grembecka. Microplastics and Oxidative Stress—Current Problems and Prospects. Antioxidants [Internet]. 2024 May 8;13(5):579–9. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11117644/\\
Das S, Lokesh Murumulla, Ghosh P, Challa S. Heavy metal-induced disruption of the autophagy-lysosomal pathway: implications for aging and neurodegenerative disorders. BioMetals. 2025 Feb 17;
Astuti Y, Wardhana A, Watkins J, Wulaningsih W. Cigarette smoking and telomere length: A systematic review of 84 studies and meta-analysis. Environmental Research [Internet]. 2017 Oct 1;158:480–9. Available from: https://www.sciencedirect.com/science/article/pii/S0013935117304334
Lotfi RA, El Zawahry KM, Kamar ZA, Hashem Z. Effects of smoking on human telomerase reverse transcriptase expression in the skin. International Journal of Dermatology. 2014 Mar 6;53(10):1205–12.
Kunzmann AT, Coleman HG, Huang WY, Berndt SI. The association of lifetime alcohol use with mortality and cancer risk in older adults: A cohort study. Rehm J, editor. PLOS Medicine. 2018 Jun 19;15(6):e1002585.
Biswas P, Adebile TV, Sejoro S, Liu M, Zhang X, Tu W, et al. Association of sleep duration and all-cause and cancer-specific mortality: results of 2004 national health interview survey (NHIS). Sleep and Biological Rhythms. 2024 Sep 3;23(1):55–65.
Lorenzo EC, Torrance BL, Haynes L. Impact of senolytic treatment on immunity, aging, and disease. Frontiers in aging. 2023 Oct 10;4.
Khosla S. Targeting Cellular Senescence With Senolytics to Improve Skeletal Health in Older Humans: A Phase 2, Single-Center, 20-week, Open-Label, Randomized Controlled Trial. [Internet]. clinicaltrials.gov. 2024. Available from: https://clinicaltrials.gov/study/NCT04313634
Yousefzadeh MJ, Zhu Y, McGowan SJ, Angelini L, Fuhrmann-Stroissnigg H, Xu M, et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. 2018 Oct;36:18–28.
Aging-US. A Longitudinal Study on Dasatinib, Quercetin, and Fisetin Senolytic Interventions [Internet]. Aging-us.com. Aging-US; 2024 [cited 2026 Feb 9]. Available from: https://www.aging-us.com/news-room/A-Longitudinal-Study-on-Dasatinib-Quercetin-and-Fisetin-Senolytic-Interventions
Lee E, Carreras-Gallo N, Lopez L, Turner L, Lin A, Mendez TL, et al. Exploring the effects of Dasatinib, Quercetin, and Fisetin on DNA methylation clocks: a longitudinal study on senolytic interventions. Aging [Internet]. 2024 Feb 22;16(4):3088–106. Available from: https://www.aging-us.com/article/205581/text
Espinoza SE, Park S, Connolly G, Qi W, Zhang N, Semwal M, et al. Effect of fasting-mimicking diet on markers of autophagy and metabolic health in human subjects. GeroScience [Internet]. 2025 Nov;10.1007/s11357-02502035-4. Available from: https://pubmed.ncbi.nlm.nih.gov/41372565/
McReynolds MR, Chellappa K, Baur JA. Age-related NAD+ decline. Experimental Gerontology. 2020 Jun;134:110888.
Sultanova Z. Anti-ageing drug rapamycin may extend life almost as effectively as restricting calories – our new research. Witchalls C, editor. 2025 Jun 19 [cited 2026 Feb 9]; Available from: https://theconversation.com/anti-ageing-drug-rapamycin-may-extend-life-almost-as-effectively-as-restricting-calories-our-new-research-259169
Cutler HB, Jall-Rogg S, Senthil Thillainadesan, Cooke KC, Stewart, Sligar JM, et al. Cold exposure stimulates cross-tissue metabolic rewiring to fuel glucose-dependent thermogenesis in brown adipose tissue. Science Advances. 2025 Jun 11;11(24).
Kunutsor SK, Jae SY, Kurl S, Kauhanen J, Laukkanen JA. Inflammation, sauna bathing, and all-cause mortality in middle-aged and older Finnish men: a cohort study. European Journal of Epidemiology. 2022 Oct 18;37(12):1225–31.
Tanjaniina Laukkanen, Khan H, Zaccardi F, Laukkanen JA. Association Between Sauna Bathing and Fatal Cardiovascular and All-Cause Mortality Events. JAMA Internal Medicine [Internet]. 2015 Apr [cited 2019 Oct 15];175(4):542–8. Available from: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2130724
Rutledge J, Oh H, Wyss-Coray T. Measuring biological age using omics data. Nature Reviews Genetics. 2022 Jun 17;
Ibáñez de Opakua A, Conde R, de Diego A, Bizkarguenaga M, Embade N, Lu SC, et al. Metabolomic-based aging clocks. npj Metabolic Health and Disease [Internet]. 2025 Sep 3 [cited 2026 Jan 12];3(1). Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC12408810/
Mavromatis LA, Rosoff DB, Bell AS, Jung J, Wagner J, Lohoff FW. Multi-omic underpinnings of epigenetic aging and human longevity. Nature Communications [Internet]. 2023 Apr 19 [cited 2023 Dec 8];14(1):2236. Available from: https://www.nature.com/articles/s41467-023-37729-w
Cao H, Song Z, Duggan MR, Erus G, Srinivasan D, Tian YE, et al. Multi-organ MRI digitizes biological aging clocks across proteomics, metabolomics, and genetics. 2025 Jul 11 [cited 2026 Feb 9]; Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC12265779/
Cao H, Song Z, Duggan MR, Erus G, Srinivasan D, Tian YE, et al. Multi-organ MRI digitizes biological aging clocks across proteomics, metabolomics, and genetics. 2025 Jul 11 [cited 2026 Feb 9]; Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC12265779/
Test G. GlycanAge Test (GlycanAge Ltd.) [Internet]. Longevity Protocols. 2025 [cited 2026 Feb 9]. Available from: https://longevity-protocols.com/en/knowledge-base/diagnostics/glycanage-test-glycanage-ltd/
Krištić J, Vučković F, Menni C, Klarić L, Keser T, Beceheli I, et al. Glycans Are a Novel Biomarker of Chronological and Biological Ages. The Journals of Gerontology: Series A. 2013 Dec 10;69(7):779–89.
Ho E, Qualls C, Villareal DT. Effect of Diet, Exercise, or Both on Biological Age and Healthy Aging in Older Adults with Obesity: Secondary Analysis of a Randomized Controlled Trial. The journal of nutrition, health & aging. 2022 Jun;26(6):552–7.

‌